Top 2020 studies relevant to primary care: From the PEER team
- PMID: 33853911
- PMCID: PMC8324157
- DOI: 10.46747/cfp.6704255
Top 2020 studies relevant to primary care: From the PEER team
Abstract
Objective: To summarize high-quality studies for 10 topics from 2020 that have strong relevance to primary care practice.
Selecting the evidence: Study selection involved routine literature surveillance by a group of primary health care professionals. This included screening abstracts of high-impact journals and EvidenceAlerts, as well as searching the American College of Physicians Journal Club.
Main message: Topics of the 2020 articles most likely to affect primary care practice included whether antibiotic prophylaxis reduces maternal infections following operative vaginal birth; which second-line agent after metformin reduces cardiovascular outcomes for patients with diabetes; whether gabapentin is effective for alcohol use disorder; whether compression stockings prevent recurrent cellulitis; guideline recommendations for management of dyslipidemia to reduce cardiovascular risk; whether intermittent fasting is superior to consistent mealtimes for weight loss; whether vitamin C added to iron supplementation increases hemoglobin more than iron alone; whether antacid-lidocaine combinations are superior to antacid alone for epigastric pain; whether dapagliflozin improves renal and cardiovascular outcomes in chronic kidney disease; and whether empagliflozin improves cardiovascular outcomes in patients with heart failure. Five "runner-up" studies are also briefly reviewed.
Conclusion: Research from 2020 produced several high-quality studies in diabetes and cardiovascular disease, but also included a variety of other conditions relevant to primary care such as vaginal operative births, alcohol use disorder, weight loss, and chronic leg edema.
Copyright© 2021 the College of Family Physicians of Canada.
Similar articles
-
Top studies relevant to primary care practice.Can Fam Physician. 2018 Apr;64(4):280-285. Can Fam Physician. 2018. PMID: 29650603 Free PMC article. Review.
-
Top studies relevant to primary care from 2018: From PEER.Can Fam Physician. 2019 Apr;65(4):260-263. Can Fam Physician. 2019. PMID: 30979756 Free PMC article. Review.
-
Top studies of 2021 relevant to primary care: From the PEER team.Can Fam Physician. 2022 May;68(5):329-333. doi: 10.46747/cfp.6805329. Can Fam Physician. 2022. PMID: 35552205 Free PMC article.
-
Top studies of 2022 relevant to primary care: From the PEER team.Can Fam Physician. 2023 May;69(5):325-329. doi: 10.46747/cfp.6905325. Can Fam Physician. 2023. PMID: 37172982 Free PMC article. Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL. Endocr Pract. 2017. PMID: 28437620
References
-
- EvidenceAlerts [website]. Hamilton, ON: Health Information Research Unit. Available from: https://www.evidencealerts.com. Accessed 2021 Feb 18.
-
- Zhu J, Yu X, Zheng Y, Li J, Wang Y, Lin Y, et al. . Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map. Lancet Diabetes Endocrinol 2020;8(3):192-205. - PubMed
-
- Tsapas A, Avgerinos I, Karagiannis T, Malandris K, Manolopoulos A, Andreadis P, et al. . Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis. Ann Intern Med 2020;173(4):278-86. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical